Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
74.1M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
75.6M
-
Shares change
-
+5.3M
-
Total reported value, excl. options
-
$949M
-
Value change
-
+$68M
-
Put/Call ratio
-
0.22
-
Number of buys
-
90
-
Number of sells
-
-84
-
Price
-
$12.55
Significant Holders of Zymeworks Inc. - Common Stock, par value $0.00001 per share (ZYME) as of Q2 2025
214 filings reported holding ZYME - Zymeworks Inc. - Common Stock, par value $0.00001 per share as of Q2 2025.
Zymeworks Inc. - Common Stock, par value $0.00001 per share (ZYME) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.6M shares
.
Largest 10 shareholders include EcoR1 Capital, LLC (23M shares), Rubric Capital Management LP (4.71M shares), BVF INC/IL (4.31M shares), MORGAN STANLEY (4.18M shares), Redmile Group, LLC (4.15M shares), BlackRock, Inc. (3.79M shares), VANGUARD GROUP INC (2.46M shares), UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (2.46M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (2.04M shares), and Blackstone Inc. (1.66M shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.